Found: 15
Select item for more details and to access through your institution.
Alternative switching strategies based on regimens with a low genetic barrier: do clinicians have a choice nowadays?
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2019, v. 38, n. 3, p. 423, doi. 10.1007/s10096-018-3429-x
- By:
- Publication type:
- Article
Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 11, p. 1, doi. 10.1093/ofid/ofac610
- By:
- Publication type:
- Article
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses.
- Published in:
- BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08222-y
- By:
- Publication type:
- Article
Prostatitis bacteriana crónica con diagnóstico microbiológico: a propósito de dos casos.
- Published in:
- Revista Española de Quimioterapia, 2024, v. 37, n. 1, p. 118, doi. 10.37201/req/106.2023
- By:
- Publication type:
- Article
Infección por Helicobacter pylori en la población VIH+: una comorbilidad en la que pensar.
- Published in:
- Revista Española de Quimioterapia, 2020, v. 33, n. 1, p. 68, doi. 10.37201/req/033.2019
- By:
- Publication type:
- Article
Estrategias de prevención y tratamiento de la infección por SARS-CoV-2 (Severe Acute Respiratory Coronavirus 2) en pacientes con enfermedad renal crónica: revisión de la literatura.
- Published in:
- Nefrologia, 2024, v. 44, n. 2, p. 150, doi. 10.1016/j.nefro.2023.10.002
- By:
- Publication type:
- Article
Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 864, doi. 10.3390/jcm12030864
- By:
- Publication type:
- Article
Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV.
- Published in:
- Microorganisms, 2023, v. 11, n. 7, p. 1818, doi. 10.3390/microorganisms11071818
- By:
- Publication type:
- Article
Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study.
- Published in:
- HIV Medicine, 2023, v. 24, n. 5, p. 558, doi. 10.1111/hiv.13432
- By:
- Publication type:
- Article
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e116, doi. 10.1093/cid/ciac628
- By:
- Publication type:
- Article
Maintenance of virologic suppression and improvement in comorbidities after simplification to raltegravir plus boosted darunavir among treatment-experienced HIV-infected patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV.
- Published in:
- HIV Medicine, 2024, v. 25, n. 6, p. 684, doi. 10.1111/hiv.13617
- By:
- Publication type:
- Article
Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 7, p. 4057, doi. 10.1007/s12325-021-01804-9
- By:
- Publication type:
- Article
Effects of tenofovir on telomeres, telomerase and T cell maturational subset distribution in long-term aviraemic HIV-infected adults.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study.
- Published in:
- 2021
- By:
- Publication type:
- journal article